CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report

RATIONALE: Second diffuse large B-cell lymphoma (DLBCL) after treatment of acute lymphoblastic leukemia (ALL) is uncommon. To our knowledge, primary middle ear DLBCL which presents CD20-negative and coexpression of MYC and BCL-2 has not been reported yet. PATIENT CONCERNS: A 20-year-old Chinese man...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Chao, Huang, Ying, Shi, Mingxia, Nie, Bo, Li, Yuntao, Wu, Kun, Yang, Jinrong, Zeng, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485888/
https://www.ncbi.nlm.nih.gov/pubmed/30985716
http://dx.doi.org/10.1097/MD.0000000000015204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485888/
https://www.ncbi.nlm.nih.gov/pubmed/30985716
http://dx.doi.org/10.1097/MD.0000000000015204

Ejemplares similares